Early research (Phase 1)Active Not RecruitingNCT05509790What this trial is testingLY3484356 in Chinese Participants With Advanced Breast CancerWho this might be right forBreast Neoplasms Eli Lilly and Company 17
Testing effectiveness (Phase 2)UnknownNCT02681562What this trial is testingOlaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer PatientsWho this might be right forBreast CancerTriple Negative Breast Cancer Istituti Ospitalieri di Cremona 45
Testing effectiveness (Phase 2)Study completedNCT01421472What this trial is testingA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerWho this might be right forER Positive, Her2 Negative Breast Cancer PatientsTriple Negative Breast Cancer Patients Merrimack Pharmaceuticals 196
Large-scale testing (Phase 3)UnknownNCT05985187What this trial is testingClinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.Who this might be right forHER2-positive Breast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 412
Large-scale testing (Phase 3)Not Yet RecruitingNCT07005557What this trial is testingChemo-free in Older (≥65) Node-Positive ER+/HER2- Breast CancerWho this might be right forBreast CancerAdjuvant Therapy Fudan University 1,244
Early research (Phase 1)Study completedNCT02586675What this trial is testingTEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast CancerWho this might be right forBreast CancerBreast Cancer - FemaleBreast Cancer - Male H. Lee Moffitt Cancer Center and Research Institute 7
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT06167694What this trial is testingClinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerWho this might be right forUnresectable or Metastatic Breast Cancer Shandong Suncadia Medicine Co., Ltd. 146
Testing effectiveness (Phase 2)Study completedNCT02536742What this trial is testingPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer ETOP IBCSG Partners Foundation 124
Early research (Phase 1)Ended earlyNCT01149356What this trial is testingRO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerWho this might be right forEstrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+4 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173556What this trial is testingA Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Qilu Pharmaceutical Co., Ltd. 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05826964What this trial is testingLevels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast CancerWho this might be right forBreast CancerER-positive Breast CancerHER2-negative Breast Cancer+1 more University of Miami 24
Testing effectiveness (Phase 2)Study completedNCT01105312What this trial is testingPanobinostat and Letrozole in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 28
Testing effectiveness (Phase 2)Study completedNCT03395899What this trial is testingPre-operative Immunotherapy Combination Strategies in Breast CancerWho this might be right forBreast CancerEstrogen Receptor-positive Breast Cancer Queen Mary University of London 71
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967What this trial is testingDoxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerWho this might be right forBreast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more NRG Oncology 782
Testing effectiveness (Phase 2)Study completedNCT02015559What this trial is testingMucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving EverolimusWho this might be right forEstrogen Receptor-positive Breast CancerHER2-negative Breast CancerOral Complications+5 more Jonsson Comprehensive Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT05896566What this trial is testingA Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast CancerWho this might be right forBreast Cancer ETOP IBCSG Partners Foundation 231
Early research (Phase 1)Ended earlyNCT05489679What this trial is testingAC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Accutar Biotechnology Inc 6
Large-scale testing (Phase 3)Study completedNCT04109066What this trial is testingStudy of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast CancerWho this might be right forBreast Cancer Bristol-Myers Squibb 521
Testing effectiveness (Phase 2)Study completedNCT02971761What this trial is testingPembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast CancerWho this might be right forAndrogen Receptor PositiveEstrogen Receptor NegativeHER2/Neu Negative+3 more City of Hope Medical Center 18